Bank of New York Mellon’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-70,588
| Closed | -$1.28M | – | 4299 |
|
|
2020
Q3 | $1.28M | Buy |
70,588
+619
| +0.9% | +$11.2K | ﹤0.01% | 2965 |
|
|
2020
Q2 | $958K | Buy |
69,969
+11,524
| +20% | +$158K | ﹤0.01% | 3141 |
|
|
2020
Q1 | $836K | Buy |
58,445
+607
| +1% | +$8.68K | ﹤0.01% | 3093 |
|
|
2019
Q4 | $980K | Buy |
57,838
+2,091
| +4% | +$35.4K | ﹤0.01% | 3252 |
|
|
2019
Q3 | $858K | Sell |
55,747
-2,056
| -4% | -$31.6K | ﹤0.01% | 3253 |
|
|
2019
Q2 | $1.36M | Sell |
57,803
-3,615
| -6% | -$84.7K | ﹤0.01% | 3030 |
|
|
2019
Q1 | $1.74M | Buy |
61,418
+325
| +0.5% | +$9.21K | ﹤0.01% | 2843 |
|
|
2018
Q4 | $1.84M | Buy |
61,093
+7,635
| +14% | +$230K | ﹤0.01% | 2760 |
|
|
2018
Q3 | $1.87M | Sell |
53,458
-3,100
| -5% | -$109K | ﹤0.01% | 2870 |
|
|
2018
Q2 | $1.34M | Sell |
56,558
-8,426
| -13% | -$200K | ﹤0.01% | 3082 |
|
|
2018
Q1 | $1.67M | Buy |
64,984
+948
| +1% | +$24.3K | ﹤0.01% | 2910 |
|
|
2017
Q4 | $1.11M | Buy |
64,036
+12,968
| +25% | +$225K | ﹤0.01% | 3176 |
|
|
2017
Q3 | $1.41M | Buy |
+51,068
| New | +$1.41M | ﹤0.01% | 3020 |
|